Arcadia Biosciences, Inc. Announces Executive Changes
December 20, 2021 at 10:55 am
Share
Arcadia Biosciences, Inc. announced it has appointed Kevin Comcowich, current Chairman of the Arcadia Board of Directors, as interim chief executive officer, effective January 1, 2022, as the board of directors finalizes its search for a permanent CEO. As previously announced on September 7, 2021, the board of directors launched a national search for a new CEO as the company further expands into the consumer packaged goods (CPG) sector. Comcowich will continue to serve as board chair, a role he was appointed to in 2017. He joined the Arcadia board as an independent director in 2016 and previously served as chair of the audit committee. Matthew Plavan, Arcadia's CEO since 2019, will be departing the company as of December 31, 2021.
Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Companyâs product portfolio includes Zola Coconut Water (Zola). Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (Non-GMO) project verified and only contains 60 calories per serving. It offers Zola in different varieties, such as Original, Slightly Sweetened; Original with Pulp, Slightly Sweetened; Espresso, Slightly Sweetened; Pineapple; Lime; and others. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls.